Sunshine Biopharma, Inc.
SBFM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $10 | $8 | $10 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $4 | $3 | $4 |
| Inventory | $14 | $13 | $12 | $11 |
| Other Curr. Assets | $0 | $1 | $1 | $1 |
| Total Curr. Assets | $28 | $28 | $24 | $26 |
| Property Plant & Equip (Net) | $1 | $2 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $2 | $3 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $4 | $4 | $5 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $31 | $32 | $29 | $31 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $5 | $6 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $1 | $0 |
| Total Curr. Liab. | $7 | $6 | $6 | $6 |
| LT Debt | $1 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $7 | $6 | $6 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$73 | -$72 | -$70 | -$69 |
| AOCI | -$0 | $0 | -$1 | -$1 |
| Other Equity | $97 | $97 | $94 | $93 |
| Total Equity | $24 | $26 | $23 | $24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $31 | $32 | $29 | $31 |
| Net Debt | -$8 | -$9 | -$7 | -$9 |